ATE518005T1 - Verfahren zur diagnose und prognose von morbus alzheimer - Google Patents

Verfahren zur diagnose und prognose von morbus alzheimer

Info

Publication number
ATE518005T1
ATE518005T1 AT04767370T AT04767370T ATE518005T1 AT E518005 T1 ATE518005 T1 AT E518005T1 AT 04767370 T AT04767370 T AT 04767370T AT 04767370 T AT04767370 T AT 04767370T AT E518005 T1 ATE518005 T1 AT E518005T1
Authority
AT
Austria
Prior art keywords
prognosis
alzheimer
diagnosis
disease
Prior art date
Application number
AT04767370T
Other languages
English (en)
Inventor
Sandrine Mace
Sylvain Ricard
Emmanuelle Cousin
Laurent Pradier
Jesus Benavides
Jean-Francois Deleuze
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE518005T1 publication Critical patent/ATE518005T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04767370T 2003-06-20 2004-06-17 Verfahren zur diagnose und prognose von morbus alzheimer ATE518005T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0307501A FR2856409B1 (fr) 2003-06-20 2003-06-20 Methodes de detection de la maladie d'alzheimer
PCT/FR2004/001509 WO2004113568A2 (fr) 2003-06-20 2004-06-17 Méthodes de détection de la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
ATE518005T1 true ATE518005T1 (de) 2011-08-15

Family

ID=33484616

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04767370T ATE518005T1 (de) 2003-06-20 2004-06-17 Verfahren zur diagnose und prognose von morbus alzheimer

Country Status (24)

Country Link
EP (1) EP1639139B1 (de)
JP (1) JP4691491B2 (de)
KR (1) KR101170651B1 (de)
CN (1) CN1809645B (de)
AR (1) AR044492A1 (de)
AT (1) ATE518005T1 (de)
AU (1) AU2004249919B2 (de)
BR (1) BRPI0411658A (de)
CA (1) CA2529633C (de)
CY (1) CY1111970T1 (de)
DK (1) DK1639139T3 (de)
ES (1) ES2370491T3 (de)
FR (1) FR2856409B1 (de)
HR (1) HRP20110778T1 (de)
IL (1) IL172690A0 (de)
MX (1) MXPA05012800A (de)
NO (1) NO20060257L (de)
PL (1) PL1639139T3 (de)
PT (1) PT1639139E (de)
RU (2) RU2483108C2 (de)
SI (1) SI1639139T1 (de)
TW (1) TWI352738B (de)
WO (1) WO2004113568A2 (de)
ZA (1) ZA200509945B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2315559C1 (ru) * 2006-10-13 2008-01-27 Иван Васильевич Максимович Способ комплексной лучевой диагностики доклинических и клинических стадий болезни альцгеймера
CN103013989A (zh) * 2011-09-23 2013-04-03 深圳北京大学香港科技大学医学中心 与老年痴呆症发病相关的细胞周期依赖性激酶5的单核苷酸多态性位点
GB201212084D0 (en) * 2012-07-06 2012-08-22 Randox Lab Ltd Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment
CN102768189B (zh) * 2012-07-30 2014-11-19 黄石 一种药物筛选方法
CN104313144B (zh) * 2014-10-16 2017-02-01 卫生部北京医院 一种检测阿尔茨海默病易感性的试剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853995A (en) * 1997-01-07 1998-12-29 Research Development Foundation Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6
CA2383063A1 (en) * 1999-08-20 2001-03-01 Catriona Wilson Human abc2 transporter and uses thereof
EP1304922A2 (de) * 2000-07-20 2003-05-02 Cephalon, Inc. Nicht-menschliches säugetier mit der menschlichen fad-presenilin-mutation und seine nachkommenschaft
JP2004147502A (ja) * 2000-07-26 2004-05-27 Banyu Pharmaceut Co Ltd ヒト及びラットａｂｃａ２遺伝子
US20020169137A1 (en) * 2001-02-09 2002-11-14 Active Pass Pharmaceuticals, Inc. Regulation of amyloid precursor protein expression by modification of ABC transporter expression or activity
US20050019765A1 (en) * 2001-06-08 2005-01-27 Wellington Cheryl L Methods for treating disorders of the nervous and reproductive systems

Also Published As

Publication number Publication date
SI1639139T1 (sl) 2011-11-30
CN1809645A (zh) 2006-07-26
RU2009104533A (ru) 2010-08-20
PT1639139E (pt) 2011-10-24
RU2380423C2 (ru) 2010-01-27
KR20060029232A (ko) 2006-04-05
CY1111970T1 (el) 2015-11-04
KR101170651B1 (ko) 2012-08-03
CA2529633A1 (fr) 2004-12-29
EP1639139B1 (de) 2011-07-27
FR2856409A1 (fr) 2004-12-24
ES2370491T3 (es) 2011-12-16
RU2006101561A (ru) 2006-06-10
BRPI0411658A (pt) 2006-08-08
FR2856409B1 (fr) 2007-08-31
WO2004113568A3 (fr) 2005-05-06
WO2004113568A2 (fr) 2004-12-29
HK1090392A1 (en) 2006-12-22
RU2483108C2 (ru) 2013-05-27
IL172690A0 (en) 2006-04-10
TWI352738B (en) 2011-11-21
JP4691491B2 (ja) 2011-06-01
ZA200509945B (en) 2007-03-28
CN1809645B (zh) 2013-11-20
AR044492A1 (es) 2005-09-14
AU2004249919B2 (en) 2009-08-13
HRP20110778T1 (hr) 2011-11-30
JP2007515151A (ja) 2007-06-14
TW200517502A (en) 2005-06-01
MXPA05012800A (es) 2006-05-17
PL1639139T3 (pl) 2011-12-30
EP1639139A2 (de) 2006-03-29
NO20060257L (no) 2006-01-18
DK1639139T3 (da) 2011-11-21
AU2004249919A1 (en) 2004-12-29
CA2529633C (fr) 2014-08-05

Similar Documents

Publication Publication Date Title
ATE435012T1 (de) Verfahren zur behandlung von parkinson-krankheit
DE60219111D1 (de) Verfahren und System zur Diagnose von Turbinenmotoren
DE502004009299D1 (de) Verfahren zur Herstellung von Niobsuboxid
EP1482962A4 (de) Verfahren zur behandlung von trx-vermittelten erkrankungen
EP1588142A4 (de) Verfahren zur diagnose von rcc und anderen soliden tumoren
DE60109311D1 (de) Kit zur simultanen diagnose mehrerer ansteckender krankheiten und verfahren zu seiner herstellung
EP1701664A4 (de) System und verfahren zur behandlung von gewebe
ATE463997T1 (de) Körperreinigungstuch und verfahren zur herstellung
DK2211183T3 (da) Fremgangsmåde til diagnosticering og overvågning af Alzheimer's sygdom
DE60010309D1 (de) Verfahren zur echtzeitdarstellung von medizinischen bildern
EP1550462A4 (de) MITTEL ZUR BEHANDLUNG ODER PRûVENTION VON NIERENERKRANKUNGEN UND VERFAHREN ZUR DIAGNOSE VON NIERENERKRANKUNGEN
EP1446013A4 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
EP1689347A4 (de) Verfahren und reagenzien zur behandlund prävention und diagnose von bunyavirus infektion
DE60333304D1 (de) Gleitteil und verfahren zur herstellung des gleitteils
DE60333195D1 (de) Verfahren zur diagnose des myokardinfarktrisikos
EP1109929A4 (de) Verfahren zur diagnose von magensalz-schwundsyndrom und alzheimerscher krankheit und behandlungsverfahren
EP1812588A4 (de) Anomalitäten von phosphatase 2a (pp2a) zur diagnose und behandlung von morbus alzheimer
DE60225953D1 (de) Verfahren zur Herstellung von Polyamid
DE50200467D1 (de) SPM-Sensor und Verfahren zur Herstellung desselben
ATE518005T1 (de) Verfahren zur diagnose und prognose von morbus alzheimer
DE602004011865D1 (de) Vorrichtung und Verfahren zur Bestimmung des Körpertyps
EP1496743A4 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
DE602004027840D1 (de) Verfahren zur herstellung von thiazolopyrimidinen
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1639139

Country of ref document: EP